선택적 제품 분석
허용하는 경우 개인정보 보호를 고려한 제한적 분석을 사용해 어떤 리서치 여정이 효과적인지 파악합니다. 광고 추적기나 세션 녹화는 사용하지 않습니다. 환경설정에서 이 선택을 변경할 수 있습니다. 자세한 내용은 개인정보 처리방침.
FMC Corporation's published Strong Buy conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $880.4M | |
|---|---|---|
| Revenue (ttm) | 3.3B | |
| Net income (ttm) | -2.8B | |
| EPS (ttm) | -$22.0 | |
| Shares out | 155.5M | |
| P/E (forward) | 5.7x | |
| Dividend | $0.32 (7.20%) | |
| Volume | 6,421,718 | |
| Beta | 0.46 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $5.05B | $5.80B | $4.49B | $4.25B | $3.47B | -8.9% |
| Gross profit | $2.16B | $2.33B | $1.83B | $1.65B | $1.28B | -12.2% |
| Operating income | $1.03B | $1.14B | $555.6M | $506.5M | $-1.63B | — |
| Net income | $739.6M | $736.5M | $1.32B | $341.1M | $-2.24B | — |
| EPS (diluted) | $5.73 | $5.81 | $10.53 | $2.72 | $-17.88 | — |
| EBITDA | $1.20B | $1.30B | $786.2M | $827.9M | $-84.7M | — |
| R&D | $304.7M | $314.2M | $328.8M | $278.0M | $266.1M | -3.3% |
| SG&A | $714.1M | $775.2M | $734.3M | $644.6M | $684.9M | -1.0% |
Recent company headlines from major financial publishers.
The Base scenario envisions our primary valuation target of $23.78, assigned a 55.0% probability weighting and offering an implied return of 320.1% from the analysis price of $5.66 (as of 2026-10-16). In this pathway, distributor inventory destocking in Latin America and North America concludes through FY2027, restoring wholesale procurement toward equilibrium with grower field applications. Operating margins normalize toward historical mid-cycle levels as operating leverage returns across manufacturing assets, while proprietary formulations defend diamide insecticide market share.
The Bull scenario models an upside valuation target of $32.51, assigned a 20.0% probability weighting and delivering an implied return of 474.4% from $5.66 (as of 2026-10-16). Under this trajectory, channel inventory depletion triggers an aggressive restocking cycle across South America, supported by robust pest pressure and expanding planted acreage. High-margin specialty formulations accelerate operating margin expansion beyond mid-cycle targets, while substantial free cash flow generation enables accelerated debt paydown.
| Ke ↓ / g → | 1.5% | 1.8% | 2.0% | 2.3% | 2.5% |
|---|---|---|---|---|---|
| 6.4% | $26.1 | $27.0 | $27.9 | $28.9 | $30.1 |
| 6.9% | $24.2 | $24.9 | $25.6 | $26.5 | $27.4 |
| 7.4% | $22.6 | $23.2 | $23.8 | $24.4 | $25.2 |
| 7.9% | $21.3 | $21.7 | $22.2 | $22.8 | $23.3 |
| 8.4% | $20.1 | $20.5 | $20.9 | $21.3 | $21.8 |
Upcoming earnings date and setup when available.
매월 발행된 리서치 판이 부여한 등급입니다. 등급은 분석 시점의 가격을 공정 가치와 비교한 것이며, 판단이 맞았는지에 대한 기록이 아닙니다.
| 연도 | 1월 | 2월 | 3월 | 4월 | 5월 | 6월 | 7월 | 8월 | 9월 | 10월 | 11월 | 12월 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |